ESCR scientists are mounting a furious political assault against the lawsuit, currently back in Royce Lamberth's court urging that human
embryonic stem cell research continue to be funded by the Feds, hoping to pressure the judge to see it their way.
Not exact matches
In fact, when the 2007 paper came out, the commentaries in most scientific publications were quick to point out that, despite the success with adult
cells, there was still a need to
continue embryo - destructive
research and that it would be critical to the advancement of science that
research on
embryonic stem cells continue.
In addition, scientific journals
continue to push the issue of
embryonic stem -
cell research in their editorial and commentary sections, using it as a prime criterion to grade political candidates.
But just how close adult and reprogrammed
stem cells can come to matching the capabilities of
embryonic stem cells has become a contentious question in the debate over whether the federal government should
continue funding
research on
embryonic lines.
A federal appeals court on Tuesday granted a «stay» that allows human
embryonic stem cell (hESC)
research to
continue during an appeal of a 23 August district court preliminary injunction blocking it.
Continued support for biomedical
research, and opposition to human
embryonic stem cell studies.
This allows
embryonic stem cells to be employed as useful tools for both
research and regenerative medicine, because they can produce limitless numbers of themselves for
continued research or clinical use.
February 2010 - Italian
stem cell scientists challenge goverment EuroSyStem scientist Elena Cattaneo challenges Italian government - the story
continues In the summer of 2009, three Italian
stem celli scientists unsuccessfully challenged their government in the courts over its decision to exclude human
embryonic stem cell research from a ministerial funding call for projects on
stem cell biology.
Tensions are growing in Berlin ahead of a parliamentary vote that medical scientists say will determine whether or not Germany can
continue to participate effectively in
embryonic stem cell research.
Yamanaka believed that
research that inherently depended on the routine destruction of human
embryonic life could not
continue and another way to obtain pluripotent
stem cells had to be found.
CLI President Chuck Donovan commented, «Despite the millions of dollars spent on this
research, cures brought about by
embryonic stem cells have
continued to prove elusive, while adult
stem cell research applications have exploded.»
This ruling allows researchers to
continue feeding
embryonic stem cell cultures, experimenting with mice, and other
research activities until this court rules, the U.S. Supreme Court weighs in, or Congress passes legislation that clarifies the issues.
In September 2010, The New York Times reported that the U.S. Court of Appeals ruled that federal funding of
embryonic stem cell research could
continue under the new rules while the court considers Judge Lamberth's ruling [source: New York Times].
As the debate rages in Washington,
research continues outside the U.S. and in states that provide money or grants for
embryonic stem -
cell research.
Meanwhile,
research continues on both
embryonic and adult
stem cells.